Publikationen
(PDF-Dateien zum ansehen oder herunterladen)
» Publikationsstatistik Top Ten Publikationen
2011
First and Senior Authorship
Kloor M, Voigt AY, Schackert HK, Schirmacher P, von Knebel Doeberitz M, Blaeker H. (2011)
Analysis of EPCAM protein expression in diagnostics of Lynch syndrome
J Clin Oncol. 29(2):223-7. (IF:18.97)
Gutschner T, Baas M, Diederichs S. (2011) Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases
Genome Res. 21(11):1944-54. (IF:13.59)
Straub BK, Rickelt S, Zimbelmann R, Grund C, Kuhn C, Iken M, Ott M, Schirmacher P, Franke WW. (2011) E-N-cadherin heterodimers define novel adherens junctions connecting endoderm-derived cells
J Cell Biol. 195(5):873-87. (IF:9.92)
Brauckhoff A, Malz M, Tschaharganeh D, Malek N, Weber A, Riener MO, Soll C, Samarin J, Bissinger M, Schmidt J, Longerich T, Ehemann V, Schirmacher P, Breuhahn K. (2011) Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells
J Hepatol. 55(5):1049-57. (IF:9.33
Breinig M, Mayer P, Harjung A, Goeppert B, Malz M, Penzel R, Neumann O, Hartmann A, Dienemann H, Giaccone G, Schirmacher P, Kern MA, Chiosis G, Rieker RJ. (2011) Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors
Clin Cancer Res.17(8):2237-49. (IF:7.34)
Cooperative Contribution
Haiman CA...., Sinn HP..... Couch FJ. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer
Nat Genet. 43(12):1210-4. (IF: 36.38)
Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, Iken M, Vucur M, Weiss S, Heikenwalder M, Khan S, Gil J, Bruder D, Manns M, Schirmacher P, Tacke F, Ott M, Luedde T, Longerich T, Kubicka S, Zender L. (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.
Nature. 479(7374):547-51. (IF:36.10)
Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, Abel U, Arens A, Weichert W, Brand K, Koch M, Weitz J, Schmidt M, von Kalle C, Glimm H. (2011) Distinct types of tumor-initiating cells form human colon cancer tumors and metastases
Cell Stem Cell. 9(4):357-65. (IF:25.94)
J Clin Oncol. 29(34):4586-8. (IF:18.97)
Danckwardt S, Gantzert AS, Macher-Goeppinger S, Probst HC, Gentzel M, Wilm M, Grone HJ, Schirmacher P, Hentze MW, Kulozik AE. (2011) p38 MAPK controls prothrombin expression by regulated RNA 3' end processing
Mol Cell. 41(3):298-310. (IF:14.19)
2010
First and Senior Authorship
Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, Gdynia G, Penzel R, Longerich T, Breuhahn K, Popanda O, Plass C, Schirmacher P, Kern MA. (2010)
Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Hepatology. 52(6):2023-33.(IF:10.84)
Pellegrino R, Calvisi DF, Ladu S, Ehemann V, Staniscia T, Evert M, Dombrowski F, Schirmacher P, Longerich T. (2010)
Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
Hepatology. 51(3):857-68. (IF:10.84)
Gdynia G, Keith M, Kopitz J, Bergmann M, Fassl A, Weber AN, George J, Kees T, Zentgraf HW, Wiestler OD, Schirmacher P, Roth W. (2010)
danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondria.
Cancer Res. 70(21):8558-68. (IF:7.54)
Andrulis M, Capper D, Meyer J, Penzel R, Hartmann C, Zentgraf H, von Deimling A. (2010)
IDH1 R132H mutation is a rare event in MPN as determined by a mutation specific antibody.
Haematologica. 95(10):1797-8. (IF:6.42)
Böck BC, Tagscherer KE, Fassl A, Krämer A, Oehme I, Zentgraf HW, Keith M, Roth W. (2010)
The PEA-15 protein regulates autophagy via activation of JNK.
J Biol Chem. 285(28):21644-54. (IF:5.33)
Cooperative Contribution
Surolia I, Pirnie SP, Chellappa V, Taylor KN, Cariappa A, Moya J, Liu H, Bell DW, Driscoll DR, Diederichs S, Haider K, Netravali I, Le S, Elia R, Dow E, Lee A, Freudenberg J, De Jager PL, Chretien Y, Varki A, Macdonald ME, Gillis T, Behrens TW, Bloch D, Collier D, Korzenik J, Podolsky DK, Hafler D, Murali M, Sands B, Stone JH, Gregersen PK, Pillai S. (2010)
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity.
Nature. 466(7303):243-7. (IF:34.48)
Stolz A, Ertych N, Kienitz A, Vogel C, Schneider V, Fritz B, Jacob R, Dittmar G, Weichert W, Petersen I, Bastians H. (2010)
The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.
Nat Cell Biol. 12(5):492-9. (IF:19.53)
Feurle GE, Moos V, Schinnerling K, Geelhaar A, Allers K, Biagi F, Bläker H, Moter A, Loddenkemper C, Jansen A, Schneider T. (2010)
The immune reconstitution inflammatory syndrome in whipple disease: a cohort study.
Ann Intern Med. 153(11):710-7. (IF:16.23)
Kossatz U, Breuhahn K, Wolf B, Hardtke-Wolenski M, Wilkens L, Steinemann D, Singer S, Brass F, Kubicka S, Schlegelberger B, Schirmacher P, Manns MP, Singer JD, Malek NP. (2010)
The cyclin E regulator cullin 3 prevents mouse hepatic progenitor cells from becoming tumor-initiating cells.
J Clin Invest. 120(11):3820-33. (IF:15.39)
Chalaris A, Adam N, Sina C, Rosenstiel P, Lehmann-Koch J, Schirmacher P, Hartmann D, Cichy J, Gavrilova O, Schreiber S, Jostock T, Matthews V, Häsler R, Becker C, Neurath MF, Reiß K, Saftig P, Scheller J, Rose-John S. (2010)
Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice.
2009
First and Senior Authorship
Breinig M, Caldas-Lopes E, Goeppert B, Malz M, Rieker R, Bergmann F, Schirmacher P, Mayer M, Chiosis G, Kern MA. (2009)
Hepatology. 50(1):102-112. (IF:11.36)
Malz M, Weber A, Singer S, Riehmer V, Bissinger M, Riener MO, Longerich T, Soll C, Vogel A, Angel P, Schirmacher P, Breuhahn K. (2009)
Hepatology. 50(4):1130-9. (IF:11.36)
Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G, Gdynia G, Li L, Gretz N, Macher-Goeppinger S, Sido B, Schirmacher P, Meuer SC, Roth W. (2009)
Functional characterisation of decoy receptor 3 in Crohn's disease.
Gut. 58(4):483-91. (IF:9.77)
Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M, Muley T, Meister M, Hoffmann H, Penzel R, Gdynia G, Ehemann V, Schnabel PA, Kuner R, Huber P, Schirmacher P, Breuhahn K. (2009)
Cancer Res. 69(6):2234-43. (IF:7.51)
Macher-Goeppinger S, Aulmann S, Tagscherer KE, Wagener N, Haferkamp A, Penzel R, Brauckhoff A, Hohenfellner M, Sykora J, Walczak H, Teh BT, Autschbach F, Herpel E, Schirmacher P, Roth W. (2009)
Clin Cancer Res. 15(2):650-9. (IF:6.49)
Cooperative Contribution
Begus-Nahrmann Y, Lechel A, Obenauf AC, Nalapareddy K, Peit E, Hoffmann E, Schlaudraff F, Liss B, Schirmacher P, Kestler H, Danenberg E, Barker N, Clevers H, Speicher MR, Rudolph KL. (2009)
Nat Genet. 41(10):1138-43. (IF:30.26)
Schmitz R, Hansmann ML, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G, Klapper W, Vater I, Giefing M, Gesk S, Stanelle J, Siebert R, Küppers R. (2009)
J Exp Med. 206(5):981-9. (IF:15.46)
Ceyhan GO, Bergmann F, Kadihasanoglu M, Altintas B, Demir IE, Hinz U, Müller MW, Giese T, Büchler MW, Giese NA, Friess H. (2009)
Pancreatic neuropathy and neuropathic pain-a comprehensive pathomorphological study of 546 cases.
Gastroenterology. 136(1):177-186. (IF:12.59)
Fortunato F, Bürgers H, Bergmann F, Rieger P, Büchler MW, Kroemer G, Werner J. (2009)
Gastroenterology. 137(1):350-60. (IF:12.59)
Németh J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, Breuhahn K, Gebhardt C, Schirmacher P, Hahn M, Ben-Neriah Y, Pikarsky E, Angel P, Hess J. (2009)
Hepatology. 50(4):1130-9. (IF:11.36)
2008
First and Senior Authorship
A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation.
Gastroenterology.134(1):179-91. (IF: 11.67)
Nussbaum T, Samarin J, Ehemann V, Bissinger M, Ryschich E, Khamidjanov A, Yu X, Gretz N, Schirmacher P, Breuhahn K. (2008)
Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
Hepatology. 48(1):146-56. (IF: 10.73)
Straub BK, Stoeffel P, Heid H, Zimbelmann R, Schirmacher P. (2008)
Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis.
Hepatology. 47(6):1936-46. (IF: 10.73)
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.
Hepatology. 47(2):511-520. (IF: 10.73)
* Equal Contribution*
Rabkin R, Awwad I, Chen Y, Ashley EA, Sun D, Sood S, Clusin W, Heidenreich P, Piecha G, Gross ML. (2008)
Low-dose growth hormone is cardioprotective in uremia.
J Am Soc Nephrol. 19(9):1774-83. (IF: 7.1)
Cooperative Contribution
Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kubicka S, Luk JM, Schirmacher P, McCombie WR, Wigler M, Hicks J, Hannon GJ, Powers S, (2008)
Lowe SW. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.
Cell. 135(5):852-64. (IF: 29.9)
Xue W, Krasnitz A, Lucito R, Sordella R, Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers S, Zender L, Lowe SW. (2008)
Genes Dev. 22(11):1439-44. (IF: 14.8)
Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbäurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A. (2008)
Circulation. 117(25):3216-26. (IF: 12.8)
Zöllinger A, Stühmer T, Chatterjee M, Gattenlöhner S, Haralambieva E, Müller-Hermelink HK, Andrulis M, Greiner A, Wesemeier C, Rath JC, Einsele H, Bargou RC. (2008)
Blood. 112(8):3403-11. (IF: 10.9)
Gotthardt D, Runz H, Keitel V, Fischer C, Flechtenmacher C, Wirtenberger M, Weiss KH, Imparato S, Braun A, Hemminki K, Stremmel W, Rüschendorf F, Stiehl A, Kubitz R, Burwinkel B, Schirmacher P, Knisely AS, Zschocke J, Sauer P. (2008)
Hepatology. 48(4):1157-66. (IF: 10.73)
2007
First and Senior Authorship
Gassler N, Roth W, Funke B, Schneider A, Herzog F, Tischendorf JJ, Grund K, Penzel R, Bravo IG, Mariadason J, Ehemann V, Sykora J, Haas TL, Walczak H, Ganten T, Zentgraf H, Erb P, Alonso A, Autschbach F, Schirmacher P, Knüchel R, Kopitz J. (2007)
Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
Gastroenterology. 133(2):587-98. (IF:12.46)
Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, Breuhahn K. (2007)
Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.
Hepatology. 46(3):759-68. (IF:10.45)
Breinig M, Schirmacher P, Kern MA. (2007)
Cyclooxygenase-2 (COX-2) - a therapeutic target in liver cancer?
Curr Pharm Des. 13(32):3305-15. (IF:5.27)
Esposito I, Kayed H, Keleg S, Giese T, Sage EH, Schirmacher P, Friess H, Kleeff J. (2007)
Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.
Neoplasia. 9(1):8-17. (IF:4.91)
Basal caspase activity promotes migration and invasiveness in glioblastoma cells.
Mol Cancer Res. 5(12):1232-40. (IF:4.76)
Cooperative Contribution
Schaetzlein S, Kodandaramireddy NR, Ju Z, Lechel A, Stepczynska A, Lilli DR, Clark AB, Rudolph C, Kuhnel F, Wei K, Schlegelberger B, Schirmacher P, Kunkel TA, Greenberg RA, Edelmann W, Rudolph KL. (2007)
Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice.
Cell. 130(5):863-77. (IF:29.19)
Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang C, Buer J, Lee HW, von Zglinicki T, Ganser A, Schirmacher P, Nakauchi H, Rudolph KL. (2007)
Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation.
Nat Genet. 39(1):99-105. (IF:24.18)
Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, Helmke B, Gassler N, Autschbach F, Bikker F, Strobel-Freidekind O, Gronert-Sum S, Benner A, Blaich S, Wittig R, Hudler M, Ligtenberg AJ, Madsen J, Holmskov U, Annese V, Latiano A, Schirmacher P, Amerongen AV, D'Amato M, Kioschis P, Hafner M, Poustka A, Mollenhauer J. (2007)
DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease. Gastroenterology. 133(5):1499-509. (IF:12.46)
Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, Hösel M, Schirmacher P, Tiegs G. (2007)
Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology. 133(4):1156-65. (IF:12.46)
Lechel A, Holstege H, Begus Y, Schienke A, Kamino K, Lehmann U, Kubicka S, Schirmacher P, Jonkers J, Rudolph KL. (2007)
Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
Gastroenterology. 132(4):1465-75. (IF:12.46)
2006
First and Senior Authorship
Müller-Decker K, Fürstenberger G, Annan N, Kucher D, Pohl-Arnold A, Steinbauer B, Esposito I, Chiblak S, Friess H, Schirmacher P, Berger I. (2006)
Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
Gastroenterology. 130(7):2165-78. (IF:12.39 )
Gassler N, Newrzella D, Böhm C, Lyer S, Li L, Sorgenfrei O, van Laer L, Sido B, Mollenhauer J, Poustka A, Schirmacher P, Gretz N. (2006)
Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine.
Gut. 55(8):1084-9. (IF:7.69)
Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M. (2006)
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
Cancer Res. 66(14):7059-66. (IF:7.61)
Finis K, Sültmann H, Ruschhaupt M, Buness A, Helmchen B, Kuner R, Gross ML, Fink B, Schirmacher P, Poustka A, Berger I. (2006)
Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches.
Arthritis Rheum. 54(3):1009-19. (IF:7.42)
Breuhahn K, Longerich T, Schirmacher P. (2006)
Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Oncogene. 25(27):3787-800. (IF:6.87)
Cooperative Contribution
Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P. (2006)
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.
J Clin Oncol. 24(12):1839-45. (IF:11.81)
Lenze D, Berg E, Volkmer-Engert R, Weiser AA, Greiner A, Knörr-Wittmann C, Anagnostopoulos I, Stein H, Hummel M. (2006)
Influence of antigen on the development of MALT lymphoma.
Blood.107(3):1141-8. (IF:10.13)
Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, Longerich T, Schirmacher P, Metzler F, Zankel M, Fischer C, Currie G, Brosgart C, Petersen J. (2006)
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.
Hepatology.44(3):675-84. (IF:9.79)
Wenger T, Mattern J, Penzel R, Gassler N, Haas TL, Sprick MR, Walczak H, Krammer PH, Debatin KM, Herr I. (2006)
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
Cell Death Differ.13(10):1740-51. (IF:7.79)
di Mola FF, Friess H, Köninger J, Selvaggi F, Esposito I, Büchler MW, di Sebastiano P. (2006)
Haemorrhoids and transient receptor potential vanilloid 1.
Gut. 55(11):1665-6.(IF:7.69)
2005
First and Senior Authorship
Gross ML, Amann K, Ritz E.(2005)
Nephron number and renal risk in hypertension and diabetes.
J Am Soc Nephrol.16 Suppl 1:S27-9. (IF:6.64)
Autschbach F, Eisold S, Hinz U, Zinser S, Linnebacher M, Giese T, Löffler T, Büchler MW, Schmidt J.(2005)
High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's disease.
Gut. 54(7):944-9. (IF:6.60)
Gassler N, Herr I, Schneider A, Penzel R, Langbein L, Schirmacher P, Kopitz J.(2005) Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
J Pathol. 207(3):295-300. (IF:5.33)
Gross ML, Ritz E, Korsch M, Adamczak M, Weckbach M, Mall G, Berger I, Hansen A, Amann K.(2005)
Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats.
Kidney Int.67(3):849-57. (IF:4.79)
Moinzadeh P, Breuhahn K, Stützer H, Schirmacher P.(2005)
Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade-results of an explorative CGH meta-analysis.
Br J Cancer. 92(5):935-41. (IF:3.74)
Cooperative Contribution
Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR.(2005)
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.
J Clin Invest.115(8):2083-98. (IF:14.20)
Nessling M, Richter K, Schwaenen C, Roerig P, Wrobel G, Wessendorf S, Fritz B, Bentz M, Sinn HP, Radlwimmer B, Lichter P.(2005)
Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue.
Cancer Res.65(2):439-47. (IF:7.69)
Veltkamp C, Sartor RB, Giese T, Autschbach F, Kaden I, Veltkamp R, Rost D, Kallinowski B, Stremmel W.(2005)
Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted TGepsilon26 mice leading to the prevention of colitis.
Gut.54(2):207-14. (IF:6.60)
Sträter J, Hinz U, Hasel C, Bhanot U, Mechtersheimer G, Lehnert T, Möller P.(2005)
Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.
Gut.54(5):661-5. (IF:6.60)
Stremmel W, Merle U, Zahn A, Autschbach F, Hinz U, Ehehalt R. (2005)
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut. 54(7):966-71. (IF:6.60)
2004
First and Senior Authorship
Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N, Wahl W, Lyer S, Poustka A, Otto HF, Deichmann M.(2004)
BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology. 127(6):1815-20. (IF:13.09)
Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P.(2004)
Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression.
Cancer Res. 64(17):6058-64. (IF:7.69)
Gross ML, Adamczak M, Rabe T, Harbi NA, Krtil J, Koch A, Hamar P, Amann K, Ritz E. (2004)
Beneficial Effects of Estrogens on Indices of Renal Damage in Uninephrectomized SHRsp Rats.
J Am Soc Nephrol. 15(2):348-58. (IF:6.64)
Kern MA, Schöneweiss MM, Sahi D, Bahlo M, Haugg AM, Kasper HU, Dienes HP, Käferstein H, Breuhahn K, Schirmacher P. (2004)
Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice.
Carcinogenesis. 25(7):1193-9. (IF:5.38)
Gassler N, Kopitz J, Tehrani A, Ottenwälder B, Schnölzer M, Kartenbeck J, Lyer S, Autschbach F, Poustka A, Otto HF, Mollenhauer J.(2004)
Expression of acyl-CoA synthetase 5 reflects the state of villus architecture in human small intestine.
J Pathol. 202(2):188-96. (IF:5.33)
Cooperative Contribution
Jüngst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH. (2004)
Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology. 39(6):1663-72. (IF:10.42)
Schwarzbach MH, Koesters R, Germann A, Mechtersheimer G, Geisbill J, Winkler S, Niedergethmann M, Ridder R, Buechler MW, von Knebel Doeberitz M, Willeke F.(2004) Comparable transforming capacities and differential gene expression patterns of variant FUS/CHOP fusion transcripts derived from soft tissue liposarcomas.
Oncogene. 23(40):6798-805. (IF:6.32)
Barth TF, Müller S, Pawlita M, Siebert R, Rother JU, Mechtersheimer G, Kitinya J, Bentz M, Möller P. (2004)
Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
J Pathol. 203(4):940-5. (IF:5.33)
Bosch FX, Ritter D, Enders C, Flechtenmacher C, Abel U, Dietz A, Hergenhahn M, Weidauer H. (2004)
Head and neck tumor sites differ in prevalence and spectrum of p53 alterations but these have limited prognostic value.
Int J Cancer.111(4):530-8. (IF:4.41)
Mollenhauer J, Helmke B, Medina D, Bergmann G, Gassler N, Müller H, Lyer S, Diedrichs L, Renner M, Wittig R, Blaich S, Hamann U, Madsen J, Holmskov U, Bikker F, Ligtenberg A, Carlén A, Olsson J,
